Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Kentucky
Merck Sharp & Dohme LLC
University of California, Davis
University of Michigan Rogel Cancer Center
Royal Marsden NHS Foundation Trust
University of California, San Francisco
Emory University
University of Michigan Rogel Cancer Center
City of Hope Medical Center
University of Pittsburgh
EpicentRx, Inc.
University of Chicago
University of Cincinnati
Case Comprehensive Cancer Center
Icahn School of Medicine at Mount Sinai
University of Cincinnati
University of California, Davis
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
BioMimetix JV, LLC
Children's Oncology Group
CEL-SCI Corporation
Ohio State University Comprehensive Cancer Center
Bristol-Myers Squibb
University of California, San Francisco
University of Cincinnati
University of Michigan Rogel Cancer Center
University of Cincinnati
University of Colorado, Denver
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy Oncology Group
Icahn School of Medicine at Mount Sinai
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Northwell Health
University of Pittsburgh
Southern Illinois University
University of Washington
University of Pittsburgh
Stanford University
University of Maryland, Baltimore
Swedish Orphan Biovitrum
Radiation Therapy Oncology Group
GlaxoSmithKline
Case Comprehensive Cancer Center
Duke University
Roswell Park Cancer Institute
Radiation Therapy Oncology Group
University of Alabama at Birmingham